Join Active Biomarkers at CHI’s 7^th Annual Immuno-Oncology Summit Europe returns to London’s Canary Wharf for three packed days of science and technology discussions on the recent advances in the development of promising immuno-oncology therapies.

The Summit, scheduled for 20-22 June 2023, comprises 4 conference programs, from strategies on Modulating the Tumour Microenvironment; to various treatment modalities including Next-Generation Cell-Based Immunotherapies; Bispecific and Multi-Specific Antibody Therapeutics, and Gamma Delta Immunotherapy.

Highlights include a Plenary Keynote Session featuring 4 distinguished Keynote Speakers; engaging Breakout Discussions that bring peers together to chat about current trends and latest developments on the most pressing or contentious topics; a balanced faculty of industry and academia speakers; and an Exhibit Hall showcasing the technology leaders in the IO space.

MEET US AT THIS EVENT